K-numberK242175
Device nameXOD Diathermia Radiofrequency Device
ApplicantXod, Inc.
Product codePBX
Device classClass II
Decision dateFeb 27, 2025
DecisionSubstantially Equivalent
Regulation878.4400
AI Summary extracted from FDA summary PDF · never regenerated
Intended use

The XOD Diathermia Radiofrequency Device is a portable therapeutic device that generates high-frequency radiofrequency energy to elevate tissue temperature for treating pain, muscle spasms, and improving local circulation. It also provides temporary reduction in the appearance of cellulite through topical heating delivered via monopolar electrodes.

Technological characteristics

The device operates at 442–454 kHz frequency with a maximum RF power of 350W and supports input voltage of 100–240V at 50/60 Hz. It features resistive threaded electrodes and a silicon return plate in a portable console with color touchscreen, offering adjustable treatment intensity (0–100%) and 20–30 minute treatment sessions targeting tissue temperatures of 40–45°C.

Test standards cited

The device was tested to IEC 60601-1 and IEC 60601-1-6 for electrical safety, IEC 60601-1-2 for electromagnetic compatibility (EMC), and ISO 10993-1 for biocompatibility assessment of patient-contacting components.

Substantial equivalence argument

The XOD device is substantially equivalent to the predicate Indiba device because both share identical indications for use, the same principle of operation (monopolar radiofrequency heating), overlapping frequency ranges (442–454 kHz vs. 400–449 kHz), identical maximum tissue temperature targets (40–45°C), and use resistive electrodes. Both meet the same electrical safety and EMC standards; differences in portable form factor, power output (350W vs. 200W), and treatment duration do not affect the fundamental intended use or safety profile.

Extracted by AI from the official FDA summary PDF →
Source

View the full FDA submission: accessdata.fda.gov

Researching this as a predicate?
Want a transparent AI-ranking score, AI-discovered related predicates, ongoing safety and warning-letter monitoring, full predicate chain lineage, and a drafted SE rationale — all saved to your own project? That's what an account adds.
Start free trial →

Everything you need for a 510(k) submission. Nothing you don't.

14-day free trial. No setup. Cancel anytime.

Start free trial →
Building an AI or ML-enabled device? Predicate search, PCCP tracking, and AI-specific FDA intelligence — built exclusively for AI/ML devices. Try AIFDA Intel →